However, combined usage of the CDK4/6 inhibitor palbociclib and the autophagy inhibitor HCQ results in growth arrest, accumulation of reactive oxygen species, and cellular senescence in cancers with an intact G1/S transition. This evidence concerns the gene CDK4 and cancer.